Check Your Fridge: Dr Pepper Is Recalling More Than 19,000 Cans in 3 States
The FDA has reclassified a recall for Dr Pepper Zero Sugar as a Class II recall.
The 19,203 affected sodas were recalled due to incorrect labeling, as the beverages were found to contain the same amount of sugar as regular Dr Pepper.
Customers who have purchased the recalled sodas, which were sold across three states, can return to them to their place of purchase for a full refund.The United States Food and Drug Administration (FDA) has upgraded an important recall for Dr Pepper over critical mislabeling.
On May 23, the FDA and Dr Pepper issued an initial, voluntary recall for more than 19,000 cans of Dr Pepper Zero Sugar, which, as their name implies, were labeled as having no sugar, but were later found to contain the full amount of sugar included in classic Dr Pepper. This makes the beverages potentially dangerous for those who are sensitive to sugar, including people with diabetes.
On June 5, the FDA reclassified the recall as a Class II, which it describes as a "situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
As outlined in the FDA's notice, the recall includes 19,203 cans, which were packaged in 12- or 24-pack cases of 12-fluid-ounce cans. Affected items will have the product code XXXXRS05165, and each case comes with a 'Best By' date of February 16, 2026.
The cases were distributed in Florida, Georgia, and South Carolina. If you have already bought the recalled product, the FDA notes that you can return it to your place of purchase for a full refund.
Unfortunately for consumers, this isn't the only beverage currently affected by an FDA recall. Earlier in June, Coca-Cola issued a voluntary recall of its Topo Chico mineral water in five states due to concerns about potential Pseudomonas contamination, a bacteria that can be deadly to individuals with weakened immune systems.
The Topo Chico recall included five states, Arizona, Louisiana, Nevada, New Mexico, and Texas, where the product was distributed to 40 different Costco locations. Just like with the recalled Dr Pepper Zero Sugar, consumers can simply return the mineral water to their place of purchase for a refund.
Related: 20 Million Eggs Pulled from Shelves After CDC Traces Deadly Bacteria to California Facility
Although it may seem like there's been an increase in the number of food and drink recalls over the past year, this isn't quite the case — but the number of hospitalizations associated with recalls is up year-over-year.
As Food & Wine previously reported, while the combined number of recalls issued by the FDA and the United States Department of Agriculture (USDA) declined in 2023, the number of hospitalizations and deaths caused by recalled items more than doubled, totaling 487 hospitalizations and 19 deaths in 2024. If you've accidentally purchased or consumed a recalled item, it's critical to take the issue seriously and reach out to your medical provider as necessary.Product recalled: Dr Pepper Zero Sugar, packaged in 12- or 24-pack cases of 12-fluid-ounce cans
Reason for recall: Incorrectly labeled as sugar-free
Number of cans recalled: 19,203
Product code: XXXXRS05165
States affected: Florida, Georgia, and South CarolinaRead the original article on Food & Wine
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
WebMD
24 minutes ago
- WebMD
FDA OKs New Next-Gen Pill for Rare Lung Cancer
approved a first-of-its-kind oral pill to treat a rare type of advanced lung cancer that often spreads to the brain. The new drug, known as taletrectinib but sold as Ibtrozi, is meant for adults with non-small-cell lung cancer (NSCLC) that has spread or worsened and is linked to a faulty ROS1 gene. This targeted therapy offers new hope to about 3,000 people in the U.S. and over 1 million globally who are diagnosed each year with advanced ROS1-positive NSCLC. NSCLC is the most common form of lung cancer – a leading cause of cancer-related deaths. About 2% of advanced cases are ROS1-positive, which grow faster and are harder to treat. Most patients are diagnosed in their 50s, often without a history of smoking. The cancer often spreads to the brain, seen in 35% at diagnosis and nearly 50% after treatment. This makes treatment especially challenging and highlights the need for better options. The FDA's decision was based on two clinical studies of people with ROS1-positive NSCLC. One trial involved 113 people who had previously been treated with a drug similar to Ibtrozi, while the other included 157 who had not. About 85% to 90% of those new to treatment responded to Ibtrozi, and at least 63% continued to see benefits for over a year. Among those previously treated, about 52% to 62% improved, with most (up to 83%) continuing to respond for at least six months. Ibtrozi also helped shrink brain tumors in 73% of people who were new to similar treatments, and in 63% of those who had tried one before, according to a news release by Nuvation Bio, the drug's maker. "Ibtrozi's durability of response and ability to effectively penetrate the brain, coupled with a well-characterized and manageable safety profile, further addresses these critical needs for patients," said Nathan Pennell, MD, PhD, a professor of medicine at the Cleveland Clinic and an investigator of the clinical trials. Ibtrozi belongs to a class of medicines called tyrosine kinase inhibitors (TKIs). It blocks the faulty ROS1 protein, helping slow cancer growth and spread. Ibtrozi is designed to reach the brain and keep the disease under control for longer. The FDA recommends 600 mg oral Ibtrozi pills once a day on an empty stomach, with no food two hours before or after taking it. Treatment continues until the cancer worsens or side effects become too serious. The most common side effects include things like nausea, diarrhea, tiredness, and dizziness. The FDA also warns about more serious risks, like liver and lung problems, heart rhythm issues, muscle pain, and possible harm to an unborn baby. People who use the drug should tell their doctor about all medications they're taking, including over-the-counter ones – especially anything for acid reflux. Women are advised not to breastfeed during treatment and for three weeks afterward. It's also important to protect your skin from the sun while taking the drug and for at least five days after stopping it.
Yahoo
2 hours ago
- Yahoo
Breyers ice cream recalls this popular flavor due to mislabeling, allergy concern
**Related video above: Recalls: Should you be concerned? (WJW) — With ice cream season heating up, yet another company is asking you to check your freezer for recalled treats. Unilever is recalling nearly 7,000 cartons of Breyers Chocolate Truffle Ice Cream, according to the U.S. Food and Drug Administration. The June 2 recall took place after the company said the product was mislabeled and there were undeclared allergens. Find out more about recalls and safety alerts right here The move comes after Turkeyfoot Creek Creamery in Ohio recently recalled eight of its flavors and then also Wells Dairy recalled 18,000 containers of ice cream and frozen yogurt due to potential for hard plastic pieces inside. The people at Breyers reportedly realized some containers of Chocolate Truffle Ice Cream were filled up with Rocky Road topped with a Rocky Road lid. Rocky Road, of course, has almonds, which could be harmful to those with a nut allergy. The FDA said the lid did say almonds were an ingredient. If your 1.5-quart carton of Breyers ice cream has the UPC 077567457288, it could be affected. The FDA said the ice cream was sent to 'distribution centers and retail locations across the U.S.' This recall was categorized as a Class II by the FDA, meaning: 'a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.' 'Water-resistant' spider in NE Ohio eats tadpoles, frogs, and even small fish 'People with an almond allergy should not consume the product due to risk of serious or life-threatening allergic reaction,' the company said in a statement to People. 'The safety and quality of our products is our top priority. For more information, consumers can visit or call 1-800-931-2826.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
Trump's former surgeon general rips RFK Jr.'s purge of vaccine board
President Trump's former surgeon general blasted Health and Human Services Secretary Robert F. Kennedy Jr.'s decision to fire the entirety of a federal advisory committee on vaccine guidance, saying the move jeopardizes public health and threatens public trust in health institutions. In an op-ed published by Time, former Surgeon General Jerome Adams wrote that Kennedy's recent actions cast doubt over his pledge that, 'We won't take away anyone's vaccines.' He pointed to the Food and Drug Administration's (FDA) new framework limiting access to COVID-19 vaccines; the Centers for Disease Control and Prevention (CDC) no longer recommending the shot for children and pregnant women; and the removal of members on the CDC's Advisory Committee on Immunization Practices (ACIP). 'These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems,' said Adams, who served in the Trump administration from 2017 to 2021. 'The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024 — more than breast cancer or car accidents,' he added. Kennedy announced Wednesday eight new members of the ACIP to replace the 17 that he had fired. Among the new members were noted spreaders of COVID-19 misinformation. As Endpoints News reported, two of the new picks were previously paid expert witnesses for plaintiffs in a lawsuit against Merck over its HPV and MMR vaccines. Kennedy had financial interests in the HPV vaccine lawsuit before divesting upon being confirmed. In his Thursday op-ed, Adams lamented that seniors and pregnant mothers are at a higher risk of severe COVID-19 outcomes, and the dismissal of the ACIP members only 'amplifies these concerns.' 'ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health,' he wrote. 'Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices.' In social media posts following his op-ed, Adams insinuated perjury had taken place, reposting epidemiologist and health economist Eric Feigl-Ding who said Kennedy's promises of not taking away vaccines were 'lies, damn lies.' 'No matter your stance on vaccines, or FDA, or CDC, reasonable and patriotic people should be able to agree that perjury (or even the appearance of intent to deceive Congress) is not an appropriate means to justify a desired end,' Adams said in the post on social platform X. Adams has shared criticisms, some veiled, of the Trump administration's actions and picks for key health positions in recent weeks. After Trump announced Casey Means as his new nominee for surgeon general, Adams took to social media to highlight Means's lack of credentials in comparison to prior surgeon generals such as himself. Writing on X earlier this month, Adams said, 'I do not know and have nothing against Dr. Means – but I feel strongly that the person who is leading America's Public Health Service should be held to the same standard as the people he or she is leading.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
